skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Material Type:
Artigo
Adicionar ao Meu Espaço

Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Li, Ming ; Gao, Feng ; Mascola, John R ; Stamatatos, Leonidas ; Polonis, Victoria R ; Koutsoukos, Marguerite ; Voss, Gerald ; Goepfert, Paul ; Gilbert, Peter ; Greene, Kelli M ; Bilska, Miroslawa ; Kothe, Denise L ; Salazar-Gonzalez, Jesus F ; Wei, Xiping ; Decker, Julie M ; Hahn, Beatrice H ; Montefiori, David C

Journal of Virology, 2005-08, Vol.79 (16), p.10108-10125 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

2
rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
Material Type:
Artigo
Adicionar ao Meu Espaço

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1

Montefiori, DC ; Huang, Y ; Karuna, S ; Allen, M ; Kochar, N ; Chappuis, S ; Gaillard, J ; Tomaras, G ; Graham, B ; Bart, P ; Pantaleo, G

Retrovirology, 2012-09, Vol.9 (S2), p.P132-P132, Article P132 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

3
Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
Material Type:
Artigo
Adicionar ao Meu Espaço

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein

Alexander, J ; Gurwith, M ; Mendy, J ; Vang, L ; Manayani, D ; Avanzini, J ; Guenther, B ; Farness, P ; Haynes, BF ; Liao, H ; Montefiori, DC ; LaBranche, CC ; Mayall, T

Retrovirology, 2012-09, Vol.9 (S2), p.P35-P35, Article P35 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

4
Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells
Material Type:
Artigo
Adicionar ao Meu Espaço

Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells

Sarzotti-Kelsoe, M ; Daniell, X ; Todd, CA ; Bilska, M ; LaBranche, C ; Perez, LG ; Ochsenbauer, C ; Kappes, J ; Rountree, W ; Ozaki, DA ; Kim, JH ; McLinden, R ; Denny, T ; Montefiori, DC

Retrovirology, 2012-09, Vol.9 (S2), p.P69-P69, Article P69 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

5
Robust Neutralizing Antibodies Elicited by HIV-1 JRFL Envelope Glycoprotein Trimers in Nonhuman Primates
Material Type:
Artigo
Adicionar ao Meu Espaço

Robust Neutralizing Antibodies Elicited by HIV-1 JRFL Envelope Glycoprotein Trimers in Nonhuman Primates

Chakrabarti, Bimal K ; Feng, Yu ; Sharma, Shailendra Kumar ; McKee, Krisha ; Karlsson Hedestam, Gunilla B ; Labranche, Celia C ; Montefiori, David C ; Mascola, John R ; Wyatt, Richard T

Journal of Virology, 2013-12, Vol.87 (24), p.13239-13251 [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

6
P11-07. Characterization of a new TZM-bl cell line that expresses human FcαR(CD89)
Material Type:
Artigo
Adicionar ao Meu Espaço

P11-07. Characterization of a new TZM-bl cell line that expresses human FcαR(CD89)

Perez, LG ; Costa, MR ; Montefiori, DC

Retrovirology, 2009-10, Vol.6 (S3), p.P152-P152, Article P152 [Periódico revisado por pares]

BioMed Central Ltd

Texto completo disponível

7
Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject
Material Type:
Artigo
Adicionar ao Meu Espaço

Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject

Moody, M ; Drinker, MS ; Gurley, TC ; Amos, JD ; Eudailey, JA ; Armand, LC ; Parks, R ; Gray, ES ; Morris, L ; Finzi, A ; Yang, X ; Sodroski, J ; Liao, H ; Tomaras, GD ; Montefiori, DC ; Haynes, BF

Retrovirology, 2012-09, Vol.9 (S2), p.O35-O35, Article O35 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

8
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family
Material Type:
Artigo
Adicionar ao Meu Espaço

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family

Bonsignori, M ; Pollara, J ; Moody, MA ; Kepler, TB ; Chen, X ; Gurley, TC ; Kozink, DM ; Marshall, DJ ; Whitesides, JF ; Kaewkungwal, J ; Nitayaphan, S ; Pitisuttithum, P ; Rerks-Ngarm, S ; Kim, JH ; Michael, NL ; Montefiori, DC ; Liao, H ; Ferrari, G ; Haynes, BF

Retrovirology, 2012-09, Vol.9 (S2), p.P78-P78, Article P78 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

9
Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

Williams, WB ; Jones, K ; Krambrink, A ; Grove, D ; Liu, P ; Yates, NL ; Moody, MA ; Ferrari, G ; Pollara, J ; Moodie, Z ; Morgan, CA ; Liao, H ; Montefiori, DC ; Ochsenbauer, C ; Kappes, J ; Hammer, S ; Mascola, J ; Koup, R ; Corey, L ; Nabel, G ; Gilbert, P ; Churchyard, G ; Keefer, M ; Graham, BS ; Haynes, BF ; Tomaras, GD

Retrovirology, 2012-09, Vol.9 (S2), p.O55-O55, Article O55 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

10
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
Material Type:
Artigo
Adicionar ao Meu Espaço

Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose

Sholukh, AM ; Siddappa, NB ; Shanmuganathan, V ; Lakhashe, SK ; Rasmussen, RA ; Watkins, JD ; Vyas, HK ; Mukhtar, MM ; Hemashettar, G ; Thorat, S ; Yoon, JK ; Villinger, F ; Novembre, FJ ; Landucci, G ; Forthal, DN ; Ratcliffe, S ; Robert-Guroff, M ; Polonis, V ; Montefiori, DC ; Ertl, HC ; Ruprecht, RM

Retrovirology, 2012-09, Vol.9 (S2), p.P41-P41, Article P41 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (213)
  2. Revistas revisadas por pares (207)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (215)
  2. Anais de Congresso  (2)
  3. Book Chapters  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de1991  (19)
  2. 1991Até1997  (37)
  3. 1998Até2004  (103)
  4. 2005Até2014  (49)
  5. Após 2014  (11)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.